BioCentury
ARTICLE | Emerging Company Profile

The choice between yttrium and iodine

September 23, 1996 7:00 AM UTC

Coulter & Idec

While Coulter believes there is a place for yttrium in cancer therapy, potentially against solid tumors, the company considers iodine to be a better choice for lymphomas because penetration of the antibody into tissues isn't an issue and myelosuppression is a significant risk with yttrium...